GlassScriptPhysician profile
William Dewey Lee, III
NPI 1356693881
$497.24
in general payments reported to CMS, 2019-2025
16 companies · $99.28 in 2025
The $99.28 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.31 · 2022: $126 · 2023: $35.69 · 2024: $160 · 2025: $99.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $67.63 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $62.91 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi-Aventis U.S. LLC | $48.08 | 2024 | |
| Cranial Technologies, INC | $40.86 | 2024-2025 | Doc Band |
| Neos Therapeutics, LP | $37.24 | 2022-2023 | Cotempla Xr-Odt |
| Pfizer INC. | $37.02 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.07 | 2021-2022 | |
| Alk-Abello, INC | $24.41 | 2025 | Neffy, Odactra, Grastek |
| Biomerieux INC | $23.00 | 2025 | Biofire Spotfire Control Station |
| Ironwood Pharmaceuticals, INC | $21.51 | 2024 | |
| Biomarin Pharmaceutical INC. | $20.09 | 2024 | Voxzogo 1.2mg |
| Seqirus USA INC | $18.73 | 2022 | |
| Hologic Sales and Service, LLC | $17.62 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.56 | 2024 | Relexxii |
| Nestle Healthcare Nutrition INC. | $14.61 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.